V025-5034 Screening compound: N-[3-tert-butyl-1-(3,4-dichlorophenyl)-1H-pyrazol-5-yl]-2-{N-[(furan-2-yl)methyl]-1-(2-phenylcyclopropyl)formamido}acetamide

V025-5034 Screening compound: N-[3-tert-butyl-1-(3,4-dichlorophenyl)-1H-pyrazol-5-yl]-2-{N-[(furan-2-yl)methyl]-1-(2-phenylcyclopropyl)formamido}acetamide
V025-5034 Screening compound: N-[3-tert-butyl-1-(3,4-dichlorophenyl)-1H-pyrazol-5-yl]-2-{N-[(furan-2-yl)methyl]-1-(2-phenylcyclopropyl)formamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-5034
N-[3-tert-butyl-1-(3,4-dichlorophenyl)-1H-pyrazol-5-yl]-2-{N-[(furan-2-yl)methyl]-1-(2-phenylcyclopropyl)formamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-5034

Molecular Formula

C30H30Cl2N4O3 (C30 H30 Cl2 N4 O3)

Compound Name

N-[3-tert-butyl-1-(3,4-dichlorophenyl)-1H-pyrazol-5-yl]-2-{N-[(furan-2-yl)methyl]-1-(2-phenylcyclopropyl)formamido}acetamide

IUPAC name

N-[3-tert-butyl-1-(34-dichlorophenyl)-1H-pyrazol-5-yl]-2-{N-[(furan-2-yl)methyl]-1-[(2R)-2-phenylcyclopropyl]formamido}acetamide

SMILES

CC(C)(C)c(cc1NC(CN(Cc2ccco2)C(C(C2)C2c2ccccc2)=O)=O)nn1-c(cc1)cc(Cl)c1Cl

InChI

InChI=1S/C30H30Cl2N4O3/c1-30(2,3)26-16-27(36(34-26)20-11-12-24(31)25(32)14-20)33-28(37)18-35(17-21-10-7-13-39-21)29(38)23-15-22(23)19-8-5-4-6-9-19/h4-14,16,22-23H,15,17-18H2,1-3H3,(H,33,37)/t22-,23?/m0/s1

InChI Key

AOVGNUIYZKYHON-NQCNTLBGSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

565.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

7.278

Distribution Coefficient, logD

7.277

Water Solubility, LogSw

-6.38

Polar Surface Area

61.763

Acid Dissociation Constant (pKa)

9.87

Base Dissociation Constant (pKb)

0.75

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

30.00

V025-5034 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V025-5034 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-5034?
Check Price and Availability of V025-5034, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-5034 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-5034
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-5034
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-5034 available by request